LOGIN  |  REGISTER
Amneal Pharmaceuticals

Universal Health Services Announces Offering of Senior Secured Notes

September 16, 2024 | Last Trade: US$180.11 4.31 2.45

KING OF PRUSSIA, Pa., Sept. 16, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it proposes to offer senior secured notes, subject to market conditions and other considerations. Actual terms of the senior secured notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing.  The Company intends to use the net proceeds of the offering to repay certain amounts outstanding under the Company's current tranche A term loan facility.

The offering of the senior secured notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn: Investment Grade Syndicate Desk, by telephone: 1-212-834-4533, BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255, Attn: Prospectus Department, by telephone: 1-800-294-1322 or by email:  This email address is being protected from spambots. You need JavaScript enabled to view it., Truist Securities, Inc., 303 Peachtree Street, Atlanta, GA 30308, Attn: Prospectus Department, by telephone: 800-685-4786 or by email: This email address is being protected from spambots. You need JavaScript enabled to view it., U.S. Bancorp Investments, Inc. by telephone: 877-558-2607, or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, by telephone: 1-800-645-3751 or by email:  This email address is being protected from spambots. You need JavaScript enabled to view it..

You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Certain statements in this release may constitute forward-looking statements and are subject to various risks and uncertainties as discussed in the Company's filings with the Securities and Exchange Commission. The Company is not obligated to update these forward-looking statements even if the Company's assessment of these risks and uncertainties changes.

Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.        

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB